These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10458960)

  • 1. Vaccines, pharmaceutical products, and bioterrorism: challenges for the U.S. Food and Drug Administration.
    Zoon KC
    Emerg Infect Dis; 1999; 5(4):534-6. PubMed ID: 10458960
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioterrorism: a clear and present danger.
    Lane HC; Montagne JL; Fauci AS
    Nat Med; 2001 Dec; 7(12):1271-3. PubMed ID: 11726956
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of vaccines for bio-warfare agents.
    Rosenthal SR; Clifford JC
    Dev Biol (Basel); 2002; 110():99-105. PubMed ID: 12477312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. See this goop? It kills anthrax.
    Creswell J
    Fortune; 2001 Nov; 144(9):147-8. PubMed ID: 11710273
    [No Abstract]   [Full Text] [Related]  

  • 5. Anthrax.
    Greenfield RA; Drevets DA; Gilmore MS
    J Okla State Med Assoc; 2002 Sep; 95(9):587-91. PubMed ID: 12362648
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioterrorism. DOD retreats on plan for anthrax vaccine.
    Marshall E
    Science; 2000 Jul; 289(5478):382-3. PubMed ID: 10939944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The controversial anthrax vaccine.
    Goldstein R
    Nurs Spectr (Wash D C); 1999 Jun; 9(11):20-1. PubMed ID: 10562219
    [No Abstract]   [Full Text] [Related]  

  • 8. Experts focus on infective agents of bioterrorism.
    Stephenson J
    JAMA; 2002 Feb; 287(5):575-6. PubMed ID: 11829676
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacillus anthracis and anthrax].
    Yabuuchi E
    Nihon Saikingaku Zasshi; 2003 Aug; 58(3):505-48. PubMed ID: 14524244
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjusting FDA policies to address bioterrorist threat.
    Fox JL
    Nat Biotechnol; 1999 Apr; 17(4):323-4. PubMed ID: 10207870
    [No Abstract]   [Full Text] [Related]  

  • 11. Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.
    Tierney BC; Martin SW; Franzke LH; Marano N; Reissman DB; Louchart RD; Goff JA; Rosenstein NE; Sever JL; McNeil MM;
    Clin Infect Dis; 2003 Oct; 37(7):905-11. PubMed ID: 13130401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fingerprints of anthrax bacteria].
    Myhre EB
    Lakartidningen; 2002 Apr; 99(15):1709. PubMed ID: 12025199
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in the development of next-generation anthrax vaccines.
    Friedlander AM; Little SF
    Vaccine; 2009 Nov; 27 Suppl 4():D28-32. PubMed ID: 19837282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax. 'Borrowed immunity' may save future victims.
    Enserink M
    Science; 2002 Feb; 295(5556):777. PubMed ID: 11823609
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioterrorism: what is and what may never be. Part 1.
    Emmons W
    Del Med J; 2002 May; 74(5):219-25. PubMed ID: 12063832
    [No Abstract]   [Full Text] [Related]  

  • 16. Surveillance for adverse events associated with anthrax vaccination--U.S. Department of Defense, 1998-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Apr; 49(16):341-5. PubMed ID: 10817479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A no-show vaccine--for a mere $126 million. Deal?
    Pound ET
    US News World Rep; 2001 Oct; 131(18):16. PubMed ID: 11699229
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccines in civilian defense against bioterrorism.
    Russell PK
    Emerg Infect Dis; 1999; 5(4):531-3. PubMed ID: 10458959
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparedness for an anthrax attack.
    Franz DR
    Mol Aspects Med; 2009 Dec; 30(6):503-10. PubMed ID: 19619577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax bioterrorism: lessons learned and future directions.
    Hughes JM; Gerberding JL
    Emerg Infect Dis; 2002 Oct; 8(10):1013-4. PubMed ID: 12396907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.